| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.42▼ | 3.46▼ | 3.46▼ | 3.39▲ | 3.09▲ |
| MA10 | 3.45▼ | 3.48▼ | 3.48▼ | 3.31▲ | 3.00▲ |
| MA20 | 3.49▼ | 3.40▲ | 3.40▲ | 3.09▲ | 3.31▲ |
| MA50 | 3.38▲ | 3.19▲ | 3.14▲ | 2.97▲ | 3.68▼ |
| MA100 | 3.15▲ | 2.99▲ | 2.99▲ | 3.32▲ | 2.73▲ |
| MA200 | 3.02▲ | 2.99▲ | 3.02▲ | 3.70▼ | 2.53▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.018▼ | -0.013▼ | -0.016▼ | 0.047▲ | 0.032▲ |
| RSI | 48.484▼ | 55.073▲ | 55.592▲ | 58.770▲ | 51.876▲ |
| STOCH | 8.333▼ | 26.042 | 26.042 | 78.873 | 54.956 |
| WILL %R | -100.000▼ | -94.737▼ | -94.737▼ | -22.078▲ | -25.431 |
| CCI | -85.556 | -71.854 | -71.854 | 87.998 | 98.267 |
|
Tuesday, August 25, 2026 02:56 PM
Cellectis (CLLS) holds steady as allogeneic CAR-T programs post strong ORR; watch Q4 2026 data and runway to 2027—read the outlook now.
|
|
Thursday, July 30, 2026 09:30 AM
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
|
|
Monday, May 11, 2026 01:00 AM
Looking for more tickers? Browse the full market events calendar. The most recent corporate event for Cellectis (CLLS) was Annual Meeting of Shareholders (Shareholders Meeting) on June 25, 2026 at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/08/26 | 3.48 | 3.57 | 3.40 | 3.40 | 5,600 |
| 27/08/26 | 3.55 | 3.565 | 3.4901 | 3.555 | 10,038 |
| 26/08/26 | 3.44 | 3.50 | 3.38 | 3.42 | 17,531 |
| 25/08/26 | 3.33 | 3.4705 | 3.305 | 3.42 | 15,823 |
| 24/08/26 | 3.32 | 3.32 | 3.15 | 3.15 | 16,784 |
| 21/08/26 | 3.325 | 3.48 | 3.2009 | 3.405 | 26,947 |
| 20/08/26 | 3.23 | 3.4705 | 3.23 | 3.47 | 35,254 |
| 19/08/26 | 3.12 | 3.17 | 3.109 | 3.17 | 5,927 |
| 18/08/26 | 3.02 | 3.11 | 2.99 | 3.04 | 23,638 |
| 17/08/26 | 3.14 | 3.1752 | 2.95 | 3.11 | 15,104 |
|
|
||||
|
|
||||
|
|